The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion

NCT03018444 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Interventions

DRUG: Atorvastatin
OTHER: Placebo

Sponsor

University Hospital, Gentofte, Copenhagen